1. Academic Validation
  2. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?

Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?

  • Dermatology. 2012;224(2):120-5. doi: 10.1159/000337546.
Katja Ivanova 1 Peter Itin Peter Haeusermann
Affiliations

Affiliation

  • 1 Department of Dermatology, University Hospital Basel, Basel, Switzerland. ivanovak@uhbs.ch
Abstract

Pityriasis rubra pilaris (PRP) includes a spectrum of rare chronic inflammatory disorders with papulosquamous eruptions of unknown cause. Different etiologies have been proposed such as vitamin A metabolism dysfunction, association with autoimmune disorders, Infection or malignancies. However, PRP seems to be a polygenic skin disorder. Classical systemic treatment is empirical and includes retinoids and methotrexate; however, only few series on treatments exist. Recently there has been an increasing number of reports documenting that new biologicals and in particular TNF-α blockers are safe and effective.

Figures